Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • lorendarith
    • Oct 2026

    #1

    16S triplicates

    I often see in studies that whenever people prepare samples for 16S sequencing there's often a line which says that each sample was amplified in triplicates.
    Why?

    Is there any paper out there which explains the need for having 16S samples in triplicates? I couldn't find anything informative...

    I understand why somebody would make triplicates in cases where the amplification for that sample would fail due to technical issues. You'd end up with less samples and have to repeat some maybe, but from an analysis point of view, is there really a need?
    Is it to potentially average out the variation caused during amplification or sequencing? Any papers showing this effect?

    It's not an issue if your sample size is small, but if you are dealing with 1000s of samples, it does get quite costly in terms of PCR/adapter oligo synthesis and PCR mix quantities.
    Just trying to avoid unnecessary cost...
    Last edited by Guest; 08-12-2016, 09:12 AM.
  • thermophile
    Senior Member
    • Apr 2015
    • 243

    #2
    You should amplify your sample more than once because the seqs that get amplified in the first few rounds of amplification will dominate the amplicion pool. Since this is random, more common seqs should be among the first amplified but sometimes they aren't. The more reactions you initialize the more often you should see the "true" most abundant seqs being the most abundant at the end of PCR.

    To minimize costs, you can reduce reaction volumes.

    Google "16s triplicate pcr" for lots of papers to cite.

    *"true" is a very lofty goal for 16S surveys but lets just go with it)
    Microbial ecologist, running a sequencing core. I have lots of strong opinions on how to survey communities, pretty sure some are even correct.

    Comment

    • lorendarith

      #3
      Originally posted by thermophile View Post
      You should amplify your sample more than once because the seqs that get amplified in the first few rounds of amplification will dominate the amplicion pool. Since this is random, more common seqs should be among the first amplified but sometimes they aren't. The more reactions you initialize the more often you should see the "true" most abundant seqs being the most abundant at the end of PCR.

      To minimize costs, you can reduce reaction volumes.

      Google "16s triplicate pcr" for lots of papers to cite.

      *"true" is a very lofty goal for 16S surveys but lets just go with it)
      Thanks for the answer. I am not looking for papers to cite, but for papers which speak for using more than one PCR reaction for 16S sequencing.

      If this particular case of PCR template bias is a thing, how come just three reactions would be enough to solve this issue? This would be heavily dependent on the complexity of the template DNA. I would imagine that in this case you'd need way more PCR reactions for soil samples than for human gut samples as an example. Yet studies on both settle for just 3 replicate reactions.

      There are countless 16S seq protocols which use triplicate reactions yet almost none of them explain why, not even if a single reference.

      The only paper I found which tries to look at triplicate vs. single reactions:
      Evaluating Bias of Illumina-Based Bacterial 16S rRNA Gene Profiles
      Katherine Kennedy, Michael W. Hall, Michael D. J. Lynch, Gabriel Moreno-Hagelsieb, and Josh D. Neufeld
      Appl. Environ. Microbiol. September 2014 80:18 5717-572
      2
      says:
      Pooling of triplicate amplifications was first proposed to decrease PCR bias introduced by stochastic fluctuations in amplification efficiencies (drift) (3). However, the impact of pooling has not been demonstrated previously.
      which I found is incredibly mindblowing that researchers were following this triplicate pooling practice for years without any evidence that it really helps??? Because this paper only indicates that it is very situation and could help mostly with very similar samples, to sort of reduce noise in the data.
      Continuing:
      Although one would predict that pooling PCR amplifications might contribute distinct representation from low-abundance “rare biosphere” organisms, we did not detect any significant differences in key alpha diversity metrics (e.g., Shannon, Chao1, and numbers of OTUs) between pooled and individual amplicon data for each sample (data not shown).
      As a reason for pooling, this study cites a paper from 1998 which highlights template bias in a simple DNA mix yet actually doesn't show anything on replicating PCR reactions:
      Bias in Template-to-Product Ratios in Multitemplate PCR
      Martin F. Polz and Colleen M. Cavanaugh
      Appl. Environ. Microbiol. October 1998


      I'm just baffled at the lack of evidence for this practice. Figured that by now somebody could have at least taken different mock community (increasing in complexity) and amplified it in several reactions and different numbers of pools to demonstrate this particular effect, given the advance in sequencing as well as computational methods for analyses we just witnessed. Multiple companies boast about these new polymerases with decreased error rates and biases. I would find it very weird all these advances would not impact this particular pooling practice.
      Last edited by Guest; 08-15-2016, 04:08 AM.

      Comment

      • adam.geber
        Member
        • May 2014
        • 40

        #4
        I think this may be one of the papers you're seeking out: Sequence Depth, Not PCR Replication, Improves Ecological Inference from Next Generation DNA Sequencing

        The authors assess the relationship between pooled PCR replicates and diversity metrics for 16S profiling on both the 454 and the MiSeq and show little benefit to replicate PCR.

        Comment

        Latest Articles

        Collapse

        • SEQadmin2
          Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
          by SEQadmin2



          Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

          Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
          ...
          10-14-2026, 09:55 AM
        • SEQadmin2
          New Genomics Technologies Take Aim at Long-Standing Limits
          by SEQadmin2


          Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

          We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
          ...
          09-28-2026, 10:25 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, 10-22-2026, 11:13 AM
        0 responses
        27 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-22-2026, 10:48 AM
        0 responses
        20 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-15-2026, 10:52 AM
        0 responses
        37 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 10-14-2026, 05:39 AM
        0 responses
        44 views
        0 reactions
        Last Post SEQadmin2  
        Working...